<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: hypoglycemic episodes</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Risk of comorbidities up with hypoglycemia in T2DM</title>
   	 <description>(HealthDay)—For patients with type 2 diabetes, hypoglycemia, regardless of its severity, correlates with a significantly increased risk of cardiovascular events, all-cause hospitalization, and mortality, according to research published in the April issue of Diabetes Care.</description>
     <link>http://medicalxpress.com/news/2013-04-comorbidities-hypoglycemia-t2dm.html</link>
	 <category>Diabetes</category>
	 <pubDate>Mon, 08 Apr 2013 18:40:01 EST</pubDate>
	 <guid isPermaLink="false">news284661627</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/riskofcomorb.jpg" width="90" height="90" />
</item>
<item>
     <title>Alternative fuel for your brain</title>
   	 <description>Tight control of blood glucose levels is critical to mitigating the long-term complications of diabetes; however, the intensive insulin therapy required for this control is frequently accompanied by recurrent episodes of low blood sugar (hypoglycemia). Hypoglycemic episodes have been implicated in brain damage and cognitive impairment. Though the brain depends predominantly on glucose as an energy source, it can also use alternative fuels, such as lactate, to satisfy its energy requirements.</description>
     <link>http://medicalxpress.com/news/2013-04-alternative-fuel-brain.html</link>
	 <category>Medical research</category>
	 <pubDate>Mon, 01 Apr 2013 12:00:02 EST</pubDate>
	 <guid isPermaLink="false">news284032207</guid>
	 
</item>
<item>
     <title>Social networking approach to public health research raises hypoglycemia awareness</title>
   	 <description>Hypoglycemia may be a much larger problem among patients with diabetes than is currently realized, according to a study of members of a diabetes-focused social network conducted by researchers in Boston Children's Hospital's Informatics Program (CHIP). The study shows how engaging patients in research through social networking may help augment traditional surveillance methods for public health research, while simultaneously offering opportunities to promote healthy behaviors among participants.</description>
     <link>http://medicalxpress.com/news/2013-02-social-networking-approach-health-hypoglycemia.html</link>
	 <category>Diabetes</category>
	 <pubDate>Mon, 11 Feb 2013 16:00:08 EST</pubDate>
	 <guid isPermaLink="false">news279805431</guid>
	 
</item>
<item>
     <title>Dapagliflozin aids glycemic control in type 2 diabetes</title>
   	 <description>(HealthDay) -- For patients with inadequately controlled type 2 diabetes, treatment with dapagliflozin is associated with improved glycemic control, stabilized insulin dosing, and weight reductions, according to research published in the March 20 issue of the Annals of Internal Medicine.</description>
     <link>http://medicalxpress.com/news/2012-03-dapagliflozin-aids-glycemic-diabetes.html</link>
	 <category>Diabetes</category>
	 <pubDate>Tue, 20 Mar 2012 13:30:01 EST</pubDate>
	 <guid isPermaLink="false">news251465867</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/dapagliflozi.jpg" width="90" height="90" />
</item>
<item>
     <title>Safer and more effective diabetes control with basal insulin analogs</title>
   	 <description>Basal insulin analogs have revolutionized diabetes care, and especially the treatment of type 2 diabetes, enabling patients to achieve better control of blood glucose levels while reducing hypoglycemic episodes. These revolutionary, long-acting basal insulin analogs, intended to replace the natural insulin missing in diabetes, and infusion pumps that provide subcutaneous, continuous delivery of insulin to mimic the function of a normal pancreas, are described in a special supplement to Diabetes Technology &amp; Therapeutics, a peer-reviewed journal published by Mary Ann Liebert, Inc.</description>
     <link>http://medicalxpress.com/news/2011-06-safer-effective-diabetes-basal-insulin.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Fri, 24 Jun 2011 17:38:41 EST</pubDate>
	 <guid isPermaLink="false">news228155897</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/saferandmore.jpg" width="90" height="90" />
</item>


</channel>
</rss>
